A Multi-Site Prospective Review of the Use of Continuous Glucose Monitoring in People with HIV and Diabetes
AIDS Patient Care and STDs · 05.08.2026
DOI: 10.1177/10872914261473699 ↗Kurz gefasst
Fachartikel in der Zeitschrift AIDS Patient Care and STDs, online erschienen am 05.08.2026. Verfasst von Anthony Gerber und 3 weiteren Autor:innen. Beteiligte Einrichtung: New York City Health + Hospital/Bellevue, New York, New York, USA. Die Arbeit nennt 17 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
People with HIV (PWH) have an increased risk of diabetes, and glycemic markers may underestimate glycemic burden in this population. This study prospectively evaluated the accuracy of continuous glucose monitor (CGM) derived Glucose Management Indicator (GMI) compared with A1C and fructosamine in PWH with type 2 diabetes and assessed patient satisfaction with CGM use. In this prospective observational study conducted between September 2024 and September 2025, adults with HIV and type 2 diabetes were recruited from two outpatient clinics in New York City and followed for 12 weeks using a Dexcom G7 CGM. Participants were required to maintain ≥70% CGM active time. A1C and fructosamine were obtained at study completion. Agreement between GMI, A1C, and fructosamine-derived A1C was assessed using correlation analyses and Bland–Altman plots. Patient satisfaction was evaluated using a Likert-scale survey. Forty-eight participants completed the study. GMI demonstrated strong correlation with A1C (r = 0.84, p < 0.001) and moderate correlation with fructosamine-derived A1C (r = 0.77, p < 0.001). Bland–Altman analysis showed minimal bias between GMI and A1C (MD = −0.07%), but greater systematic and proportional bias between GMI and fructosamine (MD = 0.70%). CGM utilization was high, and most participants reported improved understanding of glucose patterns and increased confidence in diabetes self-management. In PWH and type 2 diabetes, CGM-derived GMI demonstrates strong agreement with A1C and less agreement with fructosamine. CGM use was feasible and well accepted, providing important insights into glycemic patterns. These findings support CGM as a valuable adjunct to traditional glycemic markers in PWH.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- New York City Health + Hospital/Bellevue, New York, New York, USA.
- Arnold and Marie Schwartz College of Pharmacy, Brooklyn, New York, USA.
- The Brooklyn Hospital Center, Brooklyn, New York, USA.
- New York Medical College, Touro University, Valhalla, New York, USA.
ORCID-Profile: Anthony Gerber, Kathryn Jano
Zitieren
APA
Gerber, A., Longo, M., Jano, K., & Fischetti, B. (2026). A Multi-Site Prospective Review of the Use of Continuous Glucose Monitoring in People with HIV and Diabetes. AIDS Patient Care and STDs. https://doi.org/10.1177/10872914261473699
Vancouver
Gerber A, Longo M, Jano K, Fischetti B. A Multi-Site Prospective Review of the Use of Continuous Glucose Monitoring in People with HIV and Diabetes. AIDS Patient Care and STDs. 2026. doi:10.1177/10872914261473699
BibTeX
@article{Gerber2026,
author = {Gerber, Anthony and Longo, Maria and Jano, Kathryn and Fischetti, Briann},
title = {A Multi-Site Prospective Review of the Use of Continuous Glucose Monitoring in People with HIV and Diabetes},
journal = {AIDS Patient Care and STDs},
year = {2026},
doi = {10.1177/10872914261473699}
}
EUVIMED